课题基金 / 基金详情

Cytomegalovirus Immediate Early Proteins and Virion RNAs

Cytomegalovirus Immediate Early Proteins and Virion RNAs
巨细胞病毒立即早期蛋白和病毒粒子 RNA
批准号:
7908284
负责人:
THOMAS E SHENK
金额:
$17.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2011-07-31

项目摘要

项目成果

THOMAS E SHENK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human cytomegalovirus (HCMV) is the prototypical member of the beta-herpesvirus family. Epidemiological studies have shown that HCMV infection is widespread. In healthy individuals infection is generally asymptomatic, but the virus can cause serious disease in people with immature or compromised immune systems. It is the leading infectious disease cause of birth defects (primarily hearing loss) and a life- threatening adventitious agent in transplant recipients. The long-term objective of this research program is to elucidate the function of HCMV genes that regulate the interaction of the virus with its host cell and thereby control viral replication and pathogenesis. This proposal will study HCMV immediate-early gene products. These proteins and RNAs have the potential to exert profound effects on the virus-host interaction, because they are present at the very start of the infectious process. This is a renewal application that builds on our recent progress, which indicates that the UL123-coded IE1 protein controls the acetylation of proteins, reveals that the IRS1/TRS1 proteins have profound effects on the expression of viral mRNAs, and demonstrates that the so-called 5kb RNA is a stable intron. I now propose to extend these observations. My specific aims investigate the function and biochemical activities of (1) the HCMV UL122-coded IE1 protein; (2) the HCMV IRS1/TRS1 proteins; and (3) the HCMV 5kb transcript domain and its MCMV orthologue, the 7.2kb transcript domain. This project will include analysis of a laboratory strain (AD169) and a clinical isolate (VR1814, FIX) of HCMV. HCMV replication will be studied in fibroblasts, the cell commonly used to propagate HCMV; endothelial cells and epithelial cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins
  • 批准号:
    8990958
  • 项目类别:
  • 资助金额:
    $39.88万
  • 财政年份:
    2015
  • 负责人:
    THOMAS E SHENK
  • 依托单位:
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins
  • 批准号:
    9195706
  • 项目类别:
  • 资助金额:
    $39.88万
  • 财政年份:
    2015
  • 负责人:
    THOMAS E SHENK
  • 依托单位:
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins
  • 批准号:
    8885082
  • 项目类别:
  • 资助金额:
    $16.26万
  • 财政年份:
    2015
  • 负责人:
    THOMAS E SHENK
  • 依托单位:
FOLLOWING THE FATE OF HCMV GENE PRODUCTS IN HOST CELLS
  • 批准号:
    8361504
  • 项目类别:
  • 资助金额:
    $0.65万
  • 财政年份:
    2011
  • 负责人:
    THOMAS E SHENK
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: